BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 10463275)

  • 21. Surgical complications after primary nephrectomy for Wilms' tumor: report from the National Wilms' Tumor Study Group.
    Ritchey ML; Shamberger RC; Haase G; Horwitz J; Bergemann T; Breslow NE
    J Am Coll Surg; 2001 Jan; 192(1):63-8; quiz 146. PubMed ID: 11192924
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nephroblastoma in experience of pediatrics clinic from Cluj-Napoca between 1974-1997--a clinical and anatomopathological approach.
    Ples R
    Folia Med (Plovdiv); 1998; 40(3B Suppl 3):106-8. PubMed ID: 10206007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic factors for children with recurrent Wilms' tumor: results from the Second and Third National Wilms' Tumor Study.
    Grundy P; Breslow N; Green DM; Sharples K; Evans A; D'Angio GJ
    J Clin Oncol; 1989 May; 7(5):638-47. PubMed ID: 2540289
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relapse of unilateral favorable histology Wilms' tumor: significant clinicopathological factors.
    Aoba T; Urushihara N; Fukumoto K; Furuta S; Fukuzawa H; Mitsunaga M; Watanabe K; Yamoto M; Miyake H; Koyama M; Iwabuchi H; Koike J; Tatsunami S; Wakisaka M; Kitagawa H
    J Pediatr Surg; 2012 Dec; 47(12):2210-5. PubMed ID: 23217878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anaplastic nephrogenic rest.
    Argani P; Collins MH
    Am J Surg Pathol; 2006 Oct; 30(10):1339-41. PubMed ID: 17001170
    [No Abstract]   [Full Text] [Related]  

  • 26. [Wilms' tumor: reached progress and future prospects].
    Tamaro P
    Arch Ital Urol Androl; 1997 Sep; 69(4):227-32. PubMed ID: 9417294
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Botryoid Wilms tumor: a non-existent "entity" causing diagnostic and staging difficulties.
    Vujanić GM; Schiavo Lena M; Sebire NJ
    Virchows Arch; 2019 Feb; 474(2):227-234. PubMed ID: 30515564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The treatment of Wilms tumor. Results of the National Wilms Tumor Studies.
    Green DM; Thomas PR; Shochat S
    Hematol Oncol Clin North Am; 1995 Dec; 9(6):1267-74. PubMed ID: 8591964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histopathological variations among cases of Wilms' tumor in Bangladesh and its relationship with prognosis.
    Ara T; Khan WA; Ali SM
    Bangladesh Med Res Counc Bull; 1997 Aug; 23(2):56-9. PubMed ID: 9465437
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nephroblastic neoplasms.
    Khoury JD
    Clin Lab Med; 2005 Jun; 25(2):341-61, vi-vii. PubMed ID: 15848740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New definitions of focal and diffuse anaplasia in Wilms tumor: the International Society of Paediatric Oncology (SIOP) experience.
    Vujanić GM; Harms D; Sandstedt B; Weirich A; de Kraker J; Delemarre JF
    Med Pediatr Oncol; 1999 May; 32(5):317-23. PubMed ID: 10219330
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New developments in the pathology of Wilms tumor.
    Beckwith JB
    Cancer Invest; 1997; 15(2):153-62. PubMed ID: 9095211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment strategy for children with Wilms tumor].
    Fukuzawa M
    Nihon Geka Gakkai Zasshi; 2005 Jul; 106(7):422-6. PubMed ID: 16045185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bilateral Wilms' tumor with anaplasia: lessons from the National Wilms' Tumor Study.
    Hamilton TE; Green DM; Perlman EJ; Argani P; Grundy P; Ritchey ML; Shamberger RC
    J Pediatr Surg; 2006 Oct; 41(10):1641-4. PubMed ID: 17011261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retrospective validation of a new staging system for Wilms' tumor.
    Farewell VT; D'Angio GJ; Breslow N; Norkool P
    Cancer Clin Trials; 1981; 4(2):167-71. PubMed ID: 6265112
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic implications of hepatic adhesion, invasion, and metastases at diagnosis of Wilms' tumor. The National Wilms' Tumor Study Group.
    Thomas PR; Shochat SJ; Norkool P; Beckwith JB; Breslow NE; D'Angio GJ
    Cancer; 1991 Dec; 68(11):2486-8. PubMed ID: 1657359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management and outcome of inoperable Wilms tumor. A report of National Wilms Tumor Study-3.
    Ritchey ML; Pringle KC; Breslow NE; Takashima J; Moksness J; Zuppan CW; Beckwith JB; Thomas PR; Kelalis PP
    Ann Surg; 1994 Nov; 220(5):683-90. PubMed ID: 7979618
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Wilms tumour with unfavourable histology: implications for clinicians in the Third World.
    Hadley GP; Govender D; Landers G
    Med Pediatr Oncol; 2001 Jun; 36(6):652-3. PubMed ID: 11344499
    [No Abstract]   [Full Text] [Related]  

  • 39. Current therapy for Wilms' tumor.
    Metzger ML; Dome JS
    Oncologist; 2005; 10(10):815-26. PubMed ID: 16314292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group.
    Grundy PE; Breslow NE; Li S; Perlman E; Beckwith JB; Ritchey ML; Shamberger RC; Haase GM; D'Angio GJ; Donaldson M; Coppes MJ; Malogolowkin M; Shearer P; Thomas PR; Macklis R; Tomlinson G; Huff V; Green DM;
    J Clin Oncol; 2005 Oct; 23(29):7312-21. PubMed ID: 16129848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.